Tag
Suven Neurosciences, Inc.
2 articles
Suven Life Sciences AGM Approves Related Party Transaction
Suven Life Sciences convenes 37th AGM on August 25, 2026, to transact ordinary and special business including financial statement adoption.
Seeks shareholder approval for material related party transa
Suven Life Sciences Reports ₹548.6 Crore FY26 Loss, Advances Clinical Pipeline
Suven Life Sciences reported a standalone net loss of ₹548.63 crore for FY26 while raising ₹764.33 crore through preferential warrants to fund clinical development programs.
The company advanced five